Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

novartis_outside_1

Novartis reveals hard-hitting five-year data for its gene therapy Zolgensma in spinal muscular atrophy

March 25, 2020 Research and Development Novartis, Zolgensma, gene therapy, pharma, spinal muscular atrophy

Novartis has revealed five-year data on its gene therapy Zolgensma, boasting that the one-time infusion demonstrated “rapid, significant and clinically …
News
0000000_1200px-paracetamol_generico

British government protecting high demand medicine for use in COVID-19 patients

March 25, 2020 Research and Development COVID-19, china coronavirus, coronavirus

The British government has implemented new restrictions to protect high demand medicines for coronavirus patients. 80 medicines and being banned …
News
00_transportation_isolation_system_1

Results released from first clinical trial using Danoprevir to treat COVID-19

March 25, 2020 Research and Development COVID, COVID-19, Wuhan, china coronavirus, coronavirus

The first clinical trial using danoprevir (Ganovo) in treating COVID-19 has released its results, showing that it is safe and …
News

FDA approves supplemental drug application for Pfizer’s EURCRISA in children with eczema

March 25, 2020 Research and Development, Sales and Marketing eczema, eczema cream, eczema ointment

Pfizer announced that the FDA has approved its supplemental New Drug Application for EUCRISA ointment in treating 3 month year …
News
microsoftteams-image_1

Eyeforpharma Barcelona 2020 is now a free virtual event

March 25, 2020 Medical Communications, Research and Development COVID-19, Eyeforpharma Barcelona 2020, coronavirus, events, eyeforpharma, pharma

In light of the rapidly evolving impact of the COVID-19 virus, eyeforpharma has decided to turn eyeforpharma Barcelona 2020 into …
News
30020836983_0c6d0e542e_b

Demand for hydroxychloroquine soars after Trump says it can treat coronavirus

March 25, 2020 Research and Development, Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus, covid19

President Trump has continually touted the effectiveness of anti-malaria drug Hydroxychloroquine in treating coronavirus which has led to a jump …
News
partnership

AstraZeneca to leverage Silence Therapeutics’ siRNA expertise in $480mn deal

March 25, 2020 Research and Development, Sales and Marketing AstraZeneca, Silence Therapeutics, collaboration, pharma

Silence Therapeutics has revealed it has struck a new collaboration with AstraZeneca which will trigger the “acceleration and re-prioritisation of …
News
screen_shot_2020-01-29_at_16

Sustainability and security: How packaging is modernising pharma

March 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing counterfeit medicines, falsified medicines, feature, packaging, pharma

In a world living in the shadow of substandard and falsified medicines, climate change and antimicrobial resistance, pharmaceutical packaging will …
Feature

Nanovax’s seasonal flu vaccine meets Phase 3 endpoints and matches Sanofi’s Fluzone

March 24, 2020 Manufacturing and Production, Research and Development NanoFlu, Nanovax, influenza, pharma

Nanovax has reported positive Phase 3 data for its vaccine NanoFlu, with the candidate meeting its primary endpoints in the …
News
shutter

COVID-19: Gilead freezes compassionate access to remdesivir due to “overwhelming demand”, BMS and Lilly delay new study launches

March 24, 2020 Manufacturing and Production, Medical Communications, Research and Development Bristol-Myers Squibb, Eli Lilly, Gilead, Roche, cornavirus, pharma

As national governments continue to ramp up measures to contain the ongoing COVID-19 coronavirus outbreak, so too are pharma and …
News
gilead-sciences

FDA greenlights Gilead’s Epclusa in hepatitis C patients over six years old

March 20, 2020 Medical Communications, Research and Development Epclusa, Gilead, pharma

Gilead’s Epclusa (sofosbuvir and velpatasvir) has been awarded new marketing approval from the FDA in the treatment of hepatitis C …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

March 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus

The COVID-19 coronavirus continues to dominate the news: A flu drug has appeared to be effective in treating COVID-19 while …
News
astrazeneca_plaque

Japan grants orphan drug designation to Lynparza for BRCA+ unresectable pancreatic cancer

March 19, 2020 Research and Development, Sales and Marketing AstraZeneca, Japan, lynparza, pharma

AstraZeneca has confirmed that its PARP inhibitor Lynparza (olaparib) has been awarded orphan drug designation in Japan for the maintenance …
News
shutterstock_138095450

Global drug spending projected to reach $1.1 trillion by 2024, report argues

March 18, 2020 Research and Development, Sales and Marketing IQVIA, pharma, report

Total global spending on medicines is set to break $1.1 trillion by 2024, a new report released by IQVIA has …
News
15779565109_e09b063012_b_1

Fujifilm flu drug effective in treating coronavirus in Chinese clinical trials

March 18, 2020 Research and Development COVID-19, Wuhan Coronavirus, coronavirus

A flu drug has appeared to be effective in treating COVID-19, according to recent clinical trials in China. The drug, …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025